アミノアルコール誘導体

Japanese Patent JP4618250

B2

The present invention relates to a compound formula[I]: wherein X is bond, -CH₂-, -O- or -NH-, R¹ and R¹² are each independently hydrogen, halogen, lower alkyl, etc., R² is hydrogen or optionally substituted lower alkyl, R³ is hydrogen or an amino protective group, R⁴, R⁵ and R⁶ are each independently hydrogen or optionally substituted lower alkyl, R⁷ is -Z-R¹³, in which Z is bond, etc., and R¹³ is carboxy, lower alkoxycarbonyl, (lower alkylsulfonyl)carbamoyl or lower alkanoylsulfamoyl, R⁸ is -Y-R⁹, in which Y is bond, -CH₂-, -O-, -S-, etc., and R⁹ is hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R¹¹ is hydrogen, lower alkyl, lower alkoxy, etc., or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

JP7157804	Sulfonamides and compositions thereof for treating conditions associated with NLRP activity
JP6782540	Resist composition, resist pattern forming method and compound
WO/1993/011105	LEUKOTRIENE-B¿4? DERIVATIVES, PROCESS FOR PREPARING THE SAME AND MEDICAMENTS

Koji Hattori
Toda Susumu
Masashi Imanishi
Shinji Ito
Kenichi Washizuka
Takeki Araki
Minoru Sakurai
Daisuke Tanabe

JP2006520478A

January 26, 2011

December 20, 2004

Click for automatic bibliography generation  

Astellas Pharma Inc.

C07C311/51; A61K31/18; A61K31/195; A61K31/4406; A61P1/00; A61P1/04; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P9/12; A61P13/00; A61P13/02; A61P13/08; A61P25/22; A61P25/24; A61P27/06; A61P29/00; A61P43/00; C07C229/38; C07C229/56; C07C271/16; C07C271/22; C07C311/06; C07C311/13; C07C321/28; C07C323/12; C07C323/52; C07C323/63; C07D213/28; C07D213/38; C07D213/61

JP2002518374A
JP3503405A
JP2005530852A
JP2005520501A
JP2005518448A
JP2005518357A

WO2004072016A1

Morita Taku
Emiko Yano
鈴木 ▲頼▼子
Hamai Kosuke

Previous Patent: 音楽を教える方法

Next Patent: トリスルホアルミン酸カルシウムの製造方法及びそれに用いる装置